top of page
Reason for Hope and VMHLC Provide Comments to Reagan-Udall Foundation for the FDA on Advancing Treatment for PTSD
Following the September 6, 2024 public meeting hosted by the Reagan-Udall Foundation for the FDA in which agency officials joined...
Oct 31, 2024
Reason for Hope and the Veteran Mental Health Leadership Coalition Issue Statement on FDA Denying MDMA-Assisted Therapy for PTSD
August 09, 2024 (NEW YORK)  –  Reason for Hope  and its member organization, the V eteran Mental Health Leadership Coalition ,  issued...
Aug 9, 2024
Reason for Hope and VMHLC join other veterans groups in letter to Biden Administration in support of FDA approval for MDMA-AT for PTSD.
Reason for Hope and VMHLC joined twelve other veteran service organizations and veterans groups in a letter to the Biden Administration...
Aug 4, 2024
Reason for Hope & VMHLC submit comments for MDMA drug application to FDA advisory committee
Reason for Hope and VMHLC submit comments to FDA advisory committee on MDMA drug application
Jun 10, 2024
Lt. General Martin R. Steele, US Marine Corps (Ret.) on Advisory Panel of FDA Rejecting MDMA-Assisted Therapy for PTSD
Reason for Hope and VMHLC express disappointment with FDA Advisory Committee's recommendations for MDMA drug application.
Jun 10, 2024
Reason for Hope, et al. Provide Comments on FDA Draft Guidance for Clinical Investigation of Psychedelic Drugs
Reason for Hope, The Veteran Mental Health Leadership Coalition, BrainFutures, and the additional cosigners noted below provided comments...
Aug 25, 2023
bottom of page